Goldman Sachs’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.5M | Buy |
1,569,916
+269,529
| +21% | +$5.99M | ﹤0.01% | 1867 |
|
|
2025
Q4 | $33.7M | Sell |
1,300,387
-9,601
| -0.7% | -$228K | ﹤0.01% | 1847 |
|
|
2025
Q3 | $33.8M | Buy |
1,309,988
+1,087
| +0.1% | +$26.7K | ﹤0.01% | 1764 |
|
|
2025
Q2 | $31.3M | Buy |
1,308,901
+204,105
| +18% | +$5.14M | 0.01% | 1718 |
|
|
2025
Q1 | $27.5M | Buy |
1,104,796
+367,869
| +50% | +$8.81M | 0.01% | 1729 |
|
|
2024
Q4 | $13.9M | Buy |
736,927
+393,544
| +115% | +$6.91M | ﹤0.01% | 2474 |
|
|
2024
Q3 | $5.17M | Sell |
343,383
-9,487
| -3% | -$162K | ﹤0.01% | 3318 |
|
|
2024
Q2 | $10.1M | Buy |
352,870
+135,916
| +63% | +$3.87M | ﹤0.01% | 2495 |
|
|
2024
Q1 | $6.34M | Buy |
216,954
+13,900
| +7% | +$427K | ﹤0.01% | 2881 |
|
|
2023
Q4 | $6.85M | Buy |
203,054
+30,319
| +18% | +$887K | ﹤0.01% | 2876 |
|
|
2023
Q3 | $5.3M | Sell |
172,735
-19,258
| -10% | -$694K | ﹤0.01% | 2934 |
|
|
2023
Q2 | $7.69M | Buy |
191,993
+8,879
| +5% | +$367K | ﹤0.01% | 2705 |
|
|
2023
Q1 | $7.47M | Buy |
183,114
+57,096
| +45% | +$2.27M | ﹤0.01% | 2684 |
|
|
2022
Q4 | $4.87M | Buy |
126,018
+5,936
| +5% | +$289K | ﹤0.01% | 3196 |
|
|
2022
Q3 | $6.39M | Buy |
120,082
+10,973
| +10% | +$610K | ﹤0.01% | 2918 |
|
|
2022
Q2 | $6.36M | Buy |
109,109
+2,749
| +3% | +$180K | ﹤0.01% | 2907 |
|
|
2022
Q1 | $8.12M | Sell |
106,360
-70,274
| -40% | -$4.68M | ﹤0.01% | 2903 |
|
|
2021
Q4 | $10.6M | Sell |
176,634
-259,052
| -59% | -$14.3M | ﹤0.01% | 2702 |
|
|
2021
Q3 | $24.4M | Buy |
435,686
+29,181
| +7% | +$1.68M | 0.01% | 1891 |
|
|
2021
Q2 | $24.7M | Buy |
406,505
+33,967
| +9% | +$2.15M | 0.01% | 1860 |
|
|
2021
Q1 | $26.1M | Sell |
372,538
-37,641
| -9% | -$2.69M | 0.01% | 1713 |
|
|
2020
Q4 | $24.5M | Buy |
410,179
+120,641
| +42% | +$7.06M | 0.01% | 1689 |
|
|
2020
Q3 | $17.4M | Buy |
289,538
+46,733
| +19% | +$2.72M | 0.01% | 1838 |
|
|
2020
Q2 | $12.7M | Sell |
242,805
-104,822
| -30% | -$4.38M | ﹤0.01% | 2076 |
|
|
2020
Q1 | $11.7M | Buy |
347,627
+19,401
| +6% | +$806K | ﹤0.01% | 1968 |
|
|
2019
Q4 | $14.9M | Buy |
328,226
+27,913
| +9% | +$1.19M | ﹤0.01% | 2113 |
|
|
2019
Q3 | $11.4M | Buy |
300,313
+13,391
| +5% | +$534K | ﹤0.01% | 2220 |
|
|
2019
Q2 | $12.5M | Sell |
286,922
-297,035
| -51% | -$12.6M | ﹤0.01% | 2210 |
|
|
2019
Q1 | $22.2M | Sell |
583,957
-50,813
| -8% | -$1.98M | 0.01% | 1783 |
|
|
2018
Q4 | $27.3M | Buy |
634,770
+118,615
| +23% | +$5.54M | 0.01% | 1550 |
|
|
2018
Q3 | $25.4M | Buy |
516,155
+358,500
| +227% | +$15.5M | 0.01% | 1742 |
|
|
2018
Q2 | $5.05M | Sell |
157,655
-83,606
| -35% | -$2.89M | ﹤0.01% | 2956 |
|
|
2018
Q1 | $7.51M | Buy |
241,261
+97,328
| +68% | +$3.47M | ﹤0.01% | 2585 |
|
|
2017
Q4 | $6.57M | Sell |
143,933
-259,841
| -64% | -$10.3M | ﹤0.01% | 2773 |
|
|
2017
Q3 | $15.2M | Sell |
403,774
-73,917
| -15% | -$2.97M | ﹤0.01% | 2218 |
|
|
2017
Q2 | $22.8M | Buy |
477,691
+72,499
| +18% | +$3.36M | 0.01% | 1825 |
|
|
2017
Q1 | $18.5M | Buy |
405,192
+297,355
| +276% | +$12.9M | 0.01% | 1939 |
|
|
2016
Q4 | $3.48M | Sell |
107,837
-503,207
| -82% | -$16.8M | ﹤0.01% | 3375 |
|
|
2016
Q3 | $20.9M | Buy |
611,044
+51,996
| +9% | +$2.04M | 0.01% | 1857 |
|
|
2016
Q2 | $18.9M | Sell |
559,048
-167,400
| -23% | -$8.23M | 0.01% | 1827 |
|
|
2016
Q1 | $38.5M | Buy |
726,448
+124,192
| +21% | +$7.26M | 0.02% | 1255 |
|
|
2015
Q4 | $46.2M | Sell |
602,256
-489,587
| -45% | -$27.7M | 0.02% | 1182 |
|
|
2015
Q3 | $44.9M | Buy |
1,091,843
+258,240
| +31% | +$15.8M | 0.02% | 1138 |
|
|
2015
Q2 | $59M | Buy |
833,603
+747,299
| +866% | +$58.9M | 0.02% | 1002 |
|
|
2015
Q1 | $7.67M | Buy |
86,304
+56,412
| +189% | +$5.72M | ﹤0.01% | 2504 |
|
|
2014
Q4 | $2.65M | Sell |
29,892
-40,438
| -57% | -$3.83M | ﹤0.01% | 3564 |
|
|
2014
Q3 | $6.82M | Buy |
70,330
+51,222
| +268% | +$4.98M | ﹤0.01% | 2717 |
|
|
2014
Q2 | $1.75M | Buy |
19,108
+8,601
| +82% | +$655K | ﹤0.01% | 4125 |
|
|
2014
Q1 | $735K | Buy |
10,507
+3,812
| +57% | +$259K | ﹤0.01% | 4951 |
|
|
2013
Q4 | $385K | Sell |
6,695
-2,303
| -26% | -$121K | ﹤0.01% | 5502 |
|
|
2013
Q3 | $433K | Buy |
8,998
+1,967
| +28% | +$71.7K | ﹤0.01% | 5260 |
|
|
2013
Q2 | $204K | Buy |
+7,031
| New | +$203K | ﹤0.01% | 5575 |
|
Other funds holding PCRX
DPCM
VPM
VCM
